SCHEMBL15514098

SCHEMBL15514098

Nc1ncc(Sc2ncccn2)cc1Oc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ APAF1 O14727 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ GCK P35557 3/20 0.34
▸ FEN1 P39748 3/20 0.33
▸ TNK2 Q07912 2/20 0.33
▸ TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15196367 0.87 GCK (0.42) HTTFYNGCKCYP1A2CYP3A4
SCHEMBL2668582 0.87 GCK (0.47) L3MBTL1GCK
SCHEMBL15514755 0.87 MAP4K4 (0.38) FEN1TNK2TRPA1ALOX5AP
SCHEMBL15403264 0.81 USP2 (0.48) KMT2AKDM4ECA12CA1CA2
SCHEMBL15403575 0.79 KDM4E (0.35) MEN1KMT2AKDM4ECA12CA1
SCHEMBL2668523 0.76 KDR (0.47) SCN9A
SCHEMBL1330058 0.76 GCK (0.55) L3MBTL1GCK
SCHEMBL15404535 0.75 GCK (0.43) L3MBTL1GCK
SCHEMBL15403747 0.74 GCK (0.45) RAB9AL3MBTL1GCKFEN1ALOX5AP
SCHEMBL1331442 0.74 GCK (0.55) FYNGCKTNK2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140073658-A1 Dipyridylamine Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073658-A1 Dipyridylamine Derivative GCK, GCKR, GALK1 MEN1 3108/4885KMT2A 2024/4885KDM4E 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback